{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-053170","form_type":"8-K","ticker":"NUTX","cik":"0001479681","company_name":"Nutex Health Inc.","filed_at":"2025-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.498266+00:00","generated_at":"2026-05-16T18:25:21.323620+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Nutex Health Q3 2025 revenue $267.8M (+240% YoY), net income $55.4M vs loss $8.8M","bullets":["Total revenue $267.8M for Q3 2025, up 240% YoY; hospital division revenue $260.2M, up 263% YoY.","Net income attributable to Nutex of $55.4M in Q3 2025 vs net loss of $8.8M in Q3 2024; diluted EPS $7.76.","Adjusted EBITDA attributable to Nutex of $98.5M in Q3 2025 vs $9.7M in Q3 2024.","YTD 2025: revenue $723.6M (+225%), net income $59.0M vs loss $9.5M, adjusted EBITDA $243.0M.","Regained Nasdaq compliance on Nov 19, 2025 after filing delinquent 10-Q; matter closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-053170","json":"https://secwatch.observer/filing/0001628280-25-053170.json","markdown":"https://secwatch.observer/filing/0001628280-25-053170.md","text":"https://secwatch.observer/filing/0001628280-25-053170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/0001628280-25-053170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479681/000162828025053170/nutx-20251119.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:25:21.323620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}